ANAVIP 12 mg/mL
crotalidae immune F(ab)2(equine) · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Rare Disease Therapeutics, Inc
ANAVIP is a injection, powder, lyophilized, for solution containing crotalidae immune f(ab)2(equine) at 12 mg/mL, taken intravenous. Manufactured by Rare Disease Therapeutics, Inc.
Key Facts
- Brand Name
- ANAVIP
- Generic Name
- crotalidae immune F(ab)2(equine)
- NDC Code (Product)
66621-0790- Manufacturer
- Rare Disease Therapeutics, Inc
- Strength
- 12 mg/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125488
- Marketing Start
- 05/06/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is ANAVIP used for?
ANAVIP contains crotalidae immune F(ab)2(equine). It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is ANAVIP a controlled substance?
ANAVIP is not classified as a controlled substance by the DEA.
What is the generic name for ANAVIP?
The generic name for ANAVIP is crotalidae immune F(ab)2(equine). There are no other listed brand versions of crotalidae immune F(ab)2(equine).
What is the NDC code for ANAVIP 12 mg/mL?
The NDC (National Drug Code) for ANAVIP 12 mg/mL is 66621-0790, listed by Rare Disease Therapeutics, Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)